The Home Infusion Collaborative to Eliminate Central Line-Associated Bloodstream Infections (CLABSI)
消除中心静脉导管相关血流感染的家庭输液协作 (CLABSI)
基本信息
- 批准号:10269913
- 负责人:
- 金额:$ 49.99万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-09-30 至 2025-07-31
- 项目状态:未结题
- 来源:
- 关键词:
项目摘要
Patients who need long-term central venous catheters (CVCs) for chemotherapy, total parenteral nutrition (TPN),
outpatient parenteral antimicrobial therapy (OPAT), and other indications often maintain CVCs at home, with support
from home nursing and home infusion agencies. The market for home infusion therapy grows 8% a year, and currently
reaches 1.2 million patients yearly. Unlike in hospitals, home infusion therapy patients and their caregivers (i.e., family,
friends, neighbors, or even coworkers) perform day-to-day CVC care and infusion initiation after training by home
infusion or home health nurses. However, complications of home infusion therapy such as central line associated
bloodstream infections (CLABSI) have not been a focus of research or regulation. In fact, we do not currently have a
widely-accepted definition of CLABSI in home infusion therapy. Such a definition is urgently needed to perform
benchmarking and industry-wide quality initiatives. Furthermore, improved understanding how to perform this work in
home infusion therapy is needed. There is no CLABSI benchmark or reporting platform by which home infusion agencies
can compare their CLABSI rates with others. There is no centralized reporting platform. Meanwhile, while CLABSI
prevention toolkits are now standards of care in acute care hospitals, similar CLABSI prevention toolkits have not been
widely implemented in home infusion therapy. Evidence-based adaptations, such as training materials specifically
geared towards patients and informal caregivers, and specific advice on covering CVCs during bathing, have been
developed but not widely implemented. We have previously gathered stakeholders in healthcare epidemiology,
infection prevention, infusion nursing, and home infusion therapy using a modified Delphi approach to develop a pilot
home infusion CLABSI definition. Through a collaborative of five home infusion agencies in different regions of the
country, we will work, to validate and benchmark this new home infusion CLABSI definition, test the impact of feeding
benchmarked home infusion CLABSI data back to agencies on CLABSI rates, and implement a CLABSI prevention
maintenance toolkit in home infusion therapy. We will accomplish this through the following Specific Aims: (1) To
determine the validity of a candidate home infusion CLABSI surveillance definition and barriers to its implementation by
home infusion agencies, (2) To develop a benchmark for CLABSI rates in home infusion therapy patients and design and
implement a dashboard for dissemination of benchmarked rates, and (3) To adapt and implement an existing CLABSI
prevention toolkit for home infusion therapy and measure its impact on CLABSI rates in five home infusion agencies.
The major outcomes of this work will be (1) a validated home infusion CLABSI surveillance definition, (2) a benchmark
for home infusion CLABSI with a dashboard for dissemination of benchmarked rates, and (3) an understanding of the
impact of a CLABSI prevention toolkit on home infusion CLABSI rates.
需要长期中心静脉导管(CVC)进行化疗、全肠外营养(TPN)的患者,
门诊非肠道抗菌治疗(OPAT)和其他适应症通常在家中维持CVC,
从家庭护理和家庭输液机构。家庭输液治疗市场每年增长8%,目前
每年有120万患者。与医院不同,家庭输液治疗患者及其护理人员(即,家庭,
朋友、邻居或甚至同事)在家中训练后进行日常CVC护理和输注启动
输液或家庭保健护士。然而,家庭输液治疗的并发症,如中心线相关
血流感染(CLABSI)尚未成为研究或管理的焦点。事实上,我们目前没有一个
在家庭输液治疗中广泛接受的CLABSI定义。这样的定义是迫切需要执行的
基准和全行业的质量倡议。此外,提高了对如何执行这项工作的理解,
需要家庭输液治疗。没有CLABSI基准或报告平台,
可以将他们的CLABSI比率与其他人进行比较。没有集中的报告平台。与此同时,尽管CLABSI
预防工具包现在是急性护理医院的护理标准,类似的CLABSI预防工具包还没有
广泛应用于家庭输液治疗。基于证据的改编,例如具体的培训材料
针对患者和非正式护理人员,以及在洗澡时覆盖CVC的具体建议,
发展,但没有广泛实施。我们之前已经聚集了医疗流行病学的利益相关者,
感染预防、输液护理和家庭输液治疗,采用改良的德尔菲方法进行试点
家庭输液CLABSI定义。通过五个家庭输液机构在不同地区的合作,
国家,我们将努力,验证和基准这个新的家庭输液CLABSI定义,测试喂养的影响,
基准家庭输液CLABSI数据返回到机构的CLABSI率,并实施CLABSI预防
家庭输液治疗的维护工具包。我们将通过以下具体目标来实现这一目标:(1)
确定候选家庭输液CLABSI监测定义的有效性及其实施障碍,
家庭输液机构,(2)制定家庭输液治疗患者的CLABSI率基准,并设计和
实施基准费率发布仪表板,以及(3)调整和实施现有的CLABSI
家庭输液治疗的预防工具包,并衡量其对五个家庭输液机构的CLABSI率的影响。
这项工作的主要成果将是(1)一个有效的家庭输液CLABSI监测定义,(2)一个基准
对于家庭输液CLABSI,有一个用于传播基准率的仪表板,以及(3)了解
CLABSI预防工具包对家庭输液CLABSI率的影响。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Sara Condron Keller其他文献
Sara Condron Keller的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Sara Condron Keller', 18)}}的其他基金
The Home Infusion Collaborative to Eliminate Central Line-Associated Bloodstream Infections (CLABSI)
消除中心静脉导管相关血流感染的家庭输液协作 (CLABSI)
- 批准号:
10457907 - 财政年份:2020
- 资助金额:
$ 49.99万 - 项目类别:
The Home Infusion Collaborative to Eliminate Central Line-Associated Bloodstream Infections (CLABSI)
消除中心静脉导管相关血流感染的家庭输液协作 (CLABSI)
- 批准号:
10672910 - 财政年份:2020
- 资助金额:
$ 49.99万 - 项目类别:
The Home Infusion Collaborative to Eliminate Central Line-Associated Bloodstream Infections (CLABSI)
消除中心静脉导管相关血流感染的家庭输液协作 (CLABSI)
- 批准号:
10099636 - 财政年份:2020
- 资助金额:
$ 49.99万 - 项目类别:
A Patient and Healthcare Worker-Informed Approach to Identifying Barriers to and Strategies for Antibiotic Stewardship at the Hospital-to-Home Transition
采用患者和医护人员知情的方法来识别医院到家庭过渡过程中抗生素管理的障碍和策略
- 批准号:
9806718 - 财政年份:2019
- 资助金额:
$ 49.99万 - 项目类别:
Patient and Caregiver Provision of Outpatient Parenteral Antimicrobial Therapy (OPAT): A Patient-Centered Quality Improvement Initiative
为患者和护理人员提供门诊肠外抗菌治疗 (OPAT):一项以患者为中心的质量改进计划
- 批准号:
9900747 - 财政年份:2018
- 资助金额:
$ 49.99万 - 项目类别:
相似海外基金
Targeted Infusion Project: Collaborative Cloud-Edge Artificial Intelligence in Cyber-physical Systems
针对性注入项目:网络物理系统中的协作云边缘人工智能
- 批准号:
2205773 - 财政年份:2022
- 资助金额:
$ 49.99万 - 项目类别:
Standard Grant
Collaborative Research: HDR DSC: Infusion of data science and computation into engineering curricula
合作研究:HDR DSC:将数据科学和计算融入工程课程
- 批准号:
2123237 - 财政年份:2021
- 资助金额:
$ 49.99万 - 项目类别:
Standard Grant
Collaborative Research: HDR DSC: Infusion of Data Science and Computation into Engineering Curricula
合作研究:HDR DSC:将数据科学和计算融入工程课程
- 批准号:
2123244 - 财政年份:2021
- 资助金额:
$ 49.99万 - 项目类别:
Standard Grant
Collaborative Research: HDR DSC: Infusion of data science and computation into engineering curricula
合作研究:HDR DSC:将数据科学和计算融入工程课程
- 批准号:
2123343 - 财政年份:2021
- 资助金额:
$ 49.99万 - 项目类别:
Continuing Grant
Collaborative Research: HDR DSC: Infusion of Data Science and Computation into Engineering Curricula
合作研究:HDR DSC:将数据科学和计算融入工程课程
- 批准号:
2123285 - 财政年份:2021
- 资助金额:
$ 49.99万 - 项目类别:
Standard Grant
The Home Infusion Collaborative to Eliminate Central Line-Associated Bloodstream Infections (CLABSI)
消除中心静脉导管相关血流感染的家庭输液协作 (CLABSI)
- 批准号:
10457907 - 财政年份:2020
- 资助金额:
$ 49.99万 - 项目类别:
The Home Infusion Collaborative to Eliminate Central Line-Associated Bloodstream Infections (CLABSI)
消除中心静脉导管相关血流感染的家庭输液协作 (CLABSI)
- 批准号:
10672910 - 财政年份:2020
- 资助金额:
$ 49.99万 - 项目类别:
The Home Infusion Collaborative to Eliminate Central Line-Associated Bloodstream Infections (CLABSI)
消除中心静脉导管相关血流感染的家庭输液协作 (CLABSI)
- 批准号:
10099636 - 财政年份:2020
- 资助金额:
$ 49.99万 - 项目类别:
Targeted Infusion Project: Collaborative Science Initiative (CSI) Delaware
靶向输注项目:特拉华州协作科学计划 (CSI)
- 批准号:
1818572 - 财政年份:2018
- 资助金额:
$ 49.99万 - 项目类别:
Standard Grant
Collaborative Research: Numeracy Infusion for College Educators (NICE)
合作研究:大学教育工作者的计算能力注入 (NICE)
- 批准号:
1644975 - 财政年份:2017
- 资助金额:
$ 49.99万 - 项目类别:
Standard Grant